BCNI GMI-1271-301

About this trial

This Study is to Determine the Effficacy of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/Refractory Acute Myeloid Leukaemia

Patient Profile

Patients with Relapsed/Refractory Acute Myeloid Leukaemia

Where’s this trial being run?

University Hospital Galway

Can I join this study / trial?

The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.

Why not Print this page and bring it with you. It will help your doctor and research team advise you.

For more detailed information

Questions?

Here’s a list of questions you may have for your doctor or local cancer research team.


Summary Data

Name: BCNI GMI-1271-301
Number: 21-08
Full Title:

A Phase III Study to Determine the Efficacy of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/Refractory Acute Myeloid Leukaemia

Principal Investigator: Dr Janusz Krawczyk (University Hospital Galway)
Type: Industry Sponsored
Sponsor:

GlycoMimetics Incorporated

Recruitment Started: Global: 15-Oct-2018
Ireland: 15-Aug-2019
Global Recruitment Target: 380
Ireland Recruitment Target: 6